Felice Lin
Impact in
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Acute Myocardial Infarction Research 4
- Cardiac pacing and defibrillation studies 3
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Heart Failure Treatment and Management 2
- Cardiac electrophysiology and arrhythmias 1
- Surgery 4
- Coronary Interventions and Diagnostics 2
- Co-authors
- Jason H. Chen (2 shared papers)Françoise Perdreau‐Remington (2 shared papers)George F. Sensabaugh (2 shared papers)Heather A. Carleton (2 shared papers)Binh An Diep (2 shared papers)Matthew G. Davidson (1 shared paper)Emmanuel F. Mongodin (1 shared paper)Steven R. Gill (1 shared paper)
- Journals
- Journal of the American College of Cardiology (2 papers)Annals of Internal Medicine (1 paper)Alzheimer s Research & Therapy (1 paper)The Lancet (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United States
In The Last Decade
Felice Lin
12 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Clinical Biochemistry 550
- Infectious Diseases 1.3k
- Microbiology 130
- Molecular Medicine 98
- Molecular Biology 929
Countries citing papers authored by Felice Lin
This map shows the geographic impact of Felice Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felice Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felice Lin more than expected).
Fields of papers citing papers by Felice Lin
This network shows the impact of papers produced by Felice Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felice Lin. The network helps show where Felice Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Felice Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus Hit paper breakdown → | 2006 | 1284 |
| 2 | 2008 | 312 | |
| 3 | 2017 | 35 | |
| 4 | 2016 | 17 | |
| 5 | 2016 | 13 | |
| 6 | 2022 | 7 | |
| 7 | 2017 | 6 | |
| 8 | 2019 | 2 | |
| 9 | 2021 | 2 | |
| 10 | 2014 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2015 | 1 |
About Felice Lin
Felice Lin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology, having authored 12 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (4 papers), Cardiac pacing and defibrillation studies (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Coronary Interventions and Diagnostics (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Heart Failure Treatment and Management (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Mechanical Circulatory Support Devices (1 paper). The work is most often cited by research in Clinical Biochemistry (550 citations), Infectious Diseases (1.3k citations), Microbiology (130 citations), Molecular Medicine (98 citations) and Molecular Biology (929 citations). Felice Lin has collaborated with scholars based in United States. Frequent co-authors include Jason H. Chen, Françoise Perdreau‐Remington, George F. Sensabaugh, Heather A. Carleton, Binh An Diep, Matthew G. Davidson, Emmanuel F. Mongodin, Steven R. Gill, Daniel E. Cohen and Loren G. Miller. Their work appears in journals such as Journal of the American College of Cardiology, Annals of Internal Medicine, Alzheimer s Research & Therapy, The Lancet and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.